Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-...
by Schneeweiss, Andreas (Author)
, Park-Simon, Tjoung-Won (Author)
, Albanell, Joan (Author)
, Lassen, Ulrik (Author)
, Cortes, Javier (Author)
, Dieras, Veronique (Author)
, May, Marcus (Author)
, Schindler, Christoph (Author)
, Marmé, Frederik (Author)
, Cejalvo, Miguel Juan (Author)
, Martinez-Garcia, Maria (Author)
, Gonzalez, Iria (Author)
, Lopez-Martin, Jose (Author)
, Welt, Anja (Author)
, Levy, Christelle (Author)
, Joly, Florence (Author)
, Michielin, Francesca (Author)
, Jacob, Wolfgang (Author)
, Adessi, Céline (Author)
, Moisan, Annie (Author)
, Meneses-Lorente, Georgina (Author)
, Racek, Tomáš (Author)
, James, Ian (Author)
, Ceppi, Maurizio (Author)
, Hasmann, Max (Author)
, Weisser, Martin (Author)
, Cervantes, Andrés (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource